K. Dambracabry et al., IGG ANTI-50 KD LYMPHOCYTE MEMBRANE PEPTIDE ANTIBODY IN PATIENTS WITH SEZARY-SYNDROME, Journal of the American Academy of Dermatology, 34(5), 1996, pp. 777-780
Background: Recent evidence suggests that as cutaneous T-cell lymphoma
progresses, cell-mediated immunity is reduced and humoral responses a
re augmented. Objective: The present study was designed to compare the
IgG response in Sezary syndrome with that in mycosis fungoides. Metho
ds: The IgG antilymphocyte response was studied in six patients with S
ezary syndrome and in 11 patients with mycosis fungoides by means of i
mmunoblot analysis, enzyme-linked immunosorbent assay, immunohistochem
istry, and flow cytometry. Results: An IgG antilymphocyte response to
a 50 kd peptide was seen in five of the six patients with Sezary syndr
ome; however, none of the 11 patients with mycosis fungoides expressed
this response. Conclusions: An enhanced IgG immune response to 50 kd
lymphocyte peptide may be helpful in identifying disease progression i
n patients with cutaneous T-cell lymphoma.